Literature DB >> 12235093

Surveillance for hepatocellular carcinoma in liver cirrhosis: have programmes improved because patients have?

E Giannini, R Testa.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12235093      PMCID: PMC1773412          DOI: 10.1136/gut.51.4.611

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?

Authors:  E Giannini; L Arzani; P Borro; F Botta; A Fasoli; D Risso; G Celle; R Testa
Journal:  Hepatogastroenterology       Date:  2000 Sep-Oct

2.  A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.

Authors: 
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

Review 3.  Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies.

Authors:  C Rust; G J Gores
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

4.  No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group.

Authors:  T Livraghi; L Bolondi; L Buscarini; M Cottone; A Mazziotti; A Morabito; G Torzilli
Journal:  J Hepatol       Date:  1995-05       Impact factor: 25.083

5.  Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein.

Authors:  M Cottone; M Turri; M Caltagirone; P Parisi; A Orlando; G Fiorentino; R Virdone; G Fusco; R Grasso; R G Simonetti
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

6.  Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate.

Authors:  O Matsui; M Kadoya; J Yoshikawa; T Gabata; T Takashima; H Demachi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.